Enlitic, (ASX: ENL) is an Australian-listed company in the Healthcare sector with a market capitalisation of $5.0M and the 1657th-largest security on the ASX by market capitalisation. The ENL share price is $0.006, up 0.00% today and down 76.00% over the past 12 months. Shares have traded between $0.005 and $0.0455 over the past 52 weeks.
About Enlitic, Inc.
Enlitic, Inc., headquartered in Fort Collins, Colorado, is a company operating in the healthcare sector across the United States, Europe, and Japan. Specializing in artificial intelligence (AI), Enlitic develops sophisticated software solutions engineered to manage and optimize medical imaging data within radiology, covering modalities such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasound. The company licenses these AI-powered solutions to both healthcare providers and original equipment manufacturers (OEMs). Its comprehensive suite of healthcare data solutions includes ENDEX, an AI platform designed to standardize diverse medical imaging data; ENCOG, an AI-enabled solution for data anonymization that effectively safeguards protected health information (PHI) while preserving crucial clinical insights in imaging studies; and Migratek, an AI-driven data migration solution, complemented by routing services. Enlitic's offerings are specifically tailored to support healthcare IT departments, hospital executives, and clinical researchers. Incorporated in 2014, the company was previously known as You Partners, Inc.
CEO
Michael Karlgerhard Sistenich
